These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38146386)

  • 61. [A complex case of miliary pulmonary tuberculosis following intravesical BCG therapy].
    Chanal E; Bouleftour W; Dridi M; Héritier P; Gagneux-Brunon A; Vassal C; Guillot A
    Rev Med Liege; 2020 Jul; 75(7-8):518-520. PubMed ID: 32779902
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Osteomyelitis and septic arthritis after Mycobacterium Bovis BCG Therapy for Urinary Bladder Cancer.
    Lee SC; Geannette CS
    Clin Imaging; 2020 Dec; 68():179-183. PubMed ID: 32841934
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Granulomatous hepatitis, choroiditis and aortoduodenal fistula complicating intravesical Bacillus Calmette-Guérin therapy: Case report.
    Gao CQ; Mithani R; Leya J; Dawravoo L; Bhatia A; Antoine J; De Alba F; Russo PA; Fimmel CJ
    BMC Infect Dis; 2011 Sep; 11():260. PubMed ID: 21961922
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [A Case Diagnosed as Iatrogenic Vesical Tuberculosis 4 Years after Intravesical Immunotherapy Using Bacillus Calmette-Guérin (BCG) for the Treatment of Bladder Carcinoma].
    Kudo T; Iwasa N; Maeda S; Mitarai S
    Kansenshogaku Zasshi; 2016 Nov; 90(6):809-13. PubMed ID: 30277373
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Tuberculous Orchitis Following Intravesical Bacille Calmette-Guérin (BCG) Therapy.
    Klebanov N; Raghavan A
    Cureus; 2018 May; 10(5):e2703. PubMed ID: 30062077
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Systemic BCG-Osis as a Rare Side Effect of Intravesical BCG Treatment for Superficial Bladder Cancer.
    Lukacs S; Tschobotko B; Szabo NA; Symes A
    Case Rep Urol; 2013; 2013():821526. PubMed ID: 23844314
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Post-Vaccination Disseminated Bacillus Calmette Guerin Infection Among Children in Southern Iran.
    Aelami MH; Alborzi A; Pouladfar G; Geramizadeh B; Pourabbas B; Mardaneh J
    Jundishapur J Microbiol; 2015 Nov; 8(11):e25663. PubMed ID: 26862381
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Miliary tuberculosis induced by intravesical instillation of bacillus Calmette-Guérin.
    Osorio Aira S; Casadiego Matarranz L; Andrés García N; López Pedreira MR
    Radiologia (Engl Ed); 2019; 61(4):337-340. PubMed ID: 30898332
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Renal Tuberculosis Following Intravesical Bacillus Calmette-Guérin (BCG) Immunotherapy for the Treatment of Bladder Cancer.
    Bajramovic S; Alic J; Skopljak E; Chikha A; Vesnic S; Smajilbegovic V; Aganovic D
    Med Arch; 2020 Apr; 74(2):146-150. PubMed ID: 32577059
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A Case of Systemic Toxicity Related to Intravesical Bacillus Calmette-Guerin for the Treatment of Bladder Cancer.
    Gupta S; Singh B; Bhatt H; Singh S; Gupta S
    Cureus; 2021 May; 13(5):e15321. PubMed ID: 34094785
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Muscular pseudotumor revealing a mycobacterial granuloma after bacillus Calmette-Guérin therapy.
    Tailbaut E; Monge M; Compain F; Pacheco A; Charles P; Richaud C
    Rev Med Interne; 2022 Dec; 43(12):743-745. PubMed ID: 36184335
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effectiveness of Steroid Pulse Therapy for Systemic Side Effects after Bacillus Calmette-Guérin Intravesical Instillation Therapy: A Series of Five Cases.
    Umemoto T; Naruse J; Usui Y; Zakoji H; Miyakita H; Miyajima A
    Case Rep Urol; 2021; 2021():5548054. PubMed ID: 34336352
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Severe diffuse proliferative bronchiolitis complicating culture-proven disseminated BCG infection after intravesical instillation for bladder cancer.
    Notghi AAA; Hosseini F; Tsogas N
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35321917
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Sporotrichoid distributed tuberculous panniculitis as a late complication of intravesical bacillus Calmette-Guérin (BCG) immunotherapy.
    Nielens N; Marot L; Baeck M
    Int J Infect Dis; 2022 Apr; 117():247-250. PubMed ID: 33984512
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prevention of the Recurrence of Superficial Bladder Cancers: Intravesical Instillation of Bacillus Calmette-guerin Versus Bacillus Calmette-guerin Plus Epirubicin.
    Tozawa K; Okamura T; Yamada Y; Hayashi Y; Sasaki S; Kohri K
    Asian Pac J Cancer Prev; 2000; 1(3):217-220. PubMed ID: 12718668
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Calmette-Guerin bacillus disseminated infection after intravesical instillation].
    Borré S; Brustia D; Rosa F; Brondolo R; Rizzo G; Garavelli PL
    Recenti Prog Med; 2002 Apr; 93(4):247-8. PubMed ID: 11989131
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mycobacteremia and granulomatous hepatitis following initial intravesical bacillus Calmette-Guerin instillation for bladder carcinoma.
    Proctor DD; Chopra S; Rubenstein SC; Jokela JA; Uhl L
    Am J Gastroenterol; 1993 Jul; 88(7):1112-5. PubMed ID: 8317415
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Epididymo-orchitis caused by intravesically instillated bacillus Calmette-Guérin: genetically proven using a multiplex polymerase chain reaction method.
    Harada H; Seki M; Shinojima H; Miura M; Hirano T; Togashi M
    Int J Urol; 2006 Feb; 13(2):183-5. PubMed ID: 16563148
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [A Randomized Controlled Study of Intravesical Instillation Therapy of Bacillus Calmette-Guérin vs. Epirubicinin Treating Non-muscular Invasive Bladder Cancer].
    Yang WX; Shao YX; Hu X; Xiong SC; Liu Y; Li X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Mar; 52(2):326-333. PubMed ID: 33829710
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mycobacterium bovis Cerebellar Abscess Following Treatment With Bacillus Calmette-Guérin.
    Sheron MW; Holt SL; Ingram CW
    J Pharm Pract; 2017 Jun; 30(3):378-380. PubMed ID: 26966140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.